At high doses of Hepa-Merz ® Infusion concentrate, serum and urine urea levels should be monitored. If liver function is substantially impaired, the infusion rate must be adjusted to the …

Hepa-Merz ® Infusion concentrate must not be injected into an artery. Here you can download the pdf version of our Hepa-Merz product information. Package Leaflet / Patient Information

Hepa-Merz ® provides a standard of care across all stages of hepatic encephalopathy (HE). This section describes the therapeutic feautures of Hepa-Merz ® for patients experiencing the …

Hepa-Merz infusion concentrate is indicated for the treatment of concomitant diseases and sequelae conditions due to disordered detoxification capacity of the liver (e.g., liver cirrhosis) …

Hepa-Merz ® targets systemic neurotoxic ammonia. By reducing serum ammonia concentration, LOLA benefits patients with both overt and minimal hepatic encephalopathy (HE). 1-3 Bridging …

Hepa-Merz is indicated for the treatment of disorders that accompany, or are secondary to hepatic detoxification impairment (e.g. liver cirrhosis) with symptoms of latent and manifest hepatic …

At high doses of Hepa-Merz ® Infusion concentrate, serum and urine urea levels should be monitored. If liver function is substantially impaired, the infusion rate must be adjusted to the …

If treatment with Hepa-Merz ® is nevertheless thought to be necessary, the benefits and risks should be carefully assessed. It is not known whether L-ornithine-L-aspartate passes into …

At high doses of Hepa-Merz ® Infusion concentrate, serum and urine urea levels should be monitored. If liver function is substantially impaired, the infusion rate must be adjusted to the …

If treatment with Hepa-Merz ® is nevertheless thought to be necessary, the benefits and risks should be carefully assessed. It is not known whether L-ornithine-L-aspartate passes into …